Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

At ESMO TAT meeting, translating translation inhibition

March 3, 2021

Poziotinib twice daily effective in patients with EGFR/HER2 exon 20-mutant NSCLC

March 3, 2021

Phase I data reported for CC-90010 in patients with solid tumors

March 3, 2021

Applied Pharmaceutical Science identifies new RET inhibitors

March 3, 2021

First-in-human data presented for SCC-244 in NSCLC

March 3, 2021

AbbVie initiates first-in-human study of ABBV-637 as monotherapy or in combination

March 3, 2021

Carna receives CTA clearance for phase I study of BTK inhibitor AS-1763

March 2, 2021

FDA issues complete response letter for oral paclitaxel plus encequidar in metastatic breast cancer

March 2, 2021

Myoferlin inhibitor YQ-456 shows efficacy in PDX model of colorectal cancer

March 2, 2021

Alofanib shows safety and antitumor efficacy in patients with advanced gastric cancer

March 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...